Estimaciones de analistas de Wall Street para Inovio Pharmaceuticals, Inc. (INO): precio objetivo de consenso, recomendaciones de compra/mantener/venta y previsiones de ingresos, BPA y EBITDA para los próximos ejercicios.
Consenso de analistas
| Compra fuerte | 0 |
| Compra | 9 |
| Mantener | 6 |
| Venta | 2 |
| Venta fuerte | 0 |
| Analistas totales | 17 |
| Calificación media (1-5) | 0.41 |
Ratios de valoración
| Precio / Valor contable | 2.72 |
| EV / EBITDA | -0.57 |
| Rentabilidad por dividendo | 0.00% |
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos | $35.4M | $42.2M | $30.5M | $4.1M | $7.4M | $1.8M | $10.3M | $832010 | $217756 | $65343 |
| Coste de Ventas | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Bruto | $35.4M | $42.2M | $30.5M | $4.1M | $7.4M | $1.8M | $10.3M | $832010 | $217756 | $65343 |
| I+D | $88.7M | $98.6M | $95.3M | $88.0M | $94.2M | $249.2M | $187.7M | $86.7M | $75.6M | $54.2M |
| Generales y Administrativos | $23.9M | $28.3M | $29.3M | $27.2M | $37.2M | $53.8M | $90.2M | $47.6M | $37.0M | $32.7M |
| Gastos Operativos | $112.6M | $126.9M | $124.6M | $115.2M | $131.5M | $303.0M | $277.8M | $144.8M | $112.6M | $86.9M |
| Beneficio Operativo | -$76.2M | -$83.6M | -$94.1M | -$111.1M | -$124.1M | -$301.2M | -$267.6M | -$143.9M | -$112.4M | -$86.8M |
| EBITDA | -$74.1M | -$84.7M | -$89.8M | -$107.3M | -$149.6M | -$296.6M | -$270.9M | -$130.4M | -$103.9M | -$82.0M |
| Gastos por Intereses | $139249 | $25933 | 0 | $7.9M | $8.7M | $1.9M | $1.3M | $1.2M | $177833 | 0 |
| Beneficio Antes de Impuestos | -$73.7M | -$88.2M | -$94.8M | -$120.8M | -$167.5M | -$303.7M | -$279.8M | -$135.1M | -$107.3M | -$84.9M |
| Impuestos | 0 | 0 | $2.2M | -$257335 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Neto | -$73.7M | -$88.2M | -$97.0M | -$119.4M | -$166.4M | -$303.7M | -$279.8M | -$135.1M | -$107.3M | -$84.9M |
| BPA | $-1.01 | $-1.08 | $-1.05 | $-0.97 | $-1.07 | $-1.42 | $-14.07 | $-6.09 | $-3.95 | $-1.81 |
| BPA Diluido | $-1.01 | $-1.08 | $-1.05 | $-0.97 | $-1.07 | $-1.42 | $-14.07 | $-6.09 | $-3.95 | $-1.81 |
| Acciones en Circulación (Diluidas) | $6.1M | $6.8M | $7.7M | $8.2M | $12.9M | $17.4M | $19.9M | $22.2M | $27.2M | $46.9M |
Precio
| Precio | $1.15 |
| Capitalización | $79M |
| Bolsa | NASDAQ |
| País | US |
Empresas relacionadas: ABOS · ACTU · AGEN · ALEC · FATE · IRD · MCRB
Explorar sector: Healthcare · Biotechnology
Más secciones de INO: Resumen · Financieros · Valoración · Estadísticas · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones